Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Clinical characteristics of HIV-infected patients with adjudicated heart failure.

Steverson AB, Pawlowski AE, Schneider D, Nannapaneni P, Sanders JM, Achenbach CJ, Shah SJ, Lloyd-Jones DM, Feinstein MJ.

Eur J Prev Cardiol. 2017 Nov;24(16):1746-1758. doi: 10.1177/2047487317732432. Epub 2017 Sep 25.

2.

Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls.

Sanders JM, Steverson AB, Pawlowski AE, Schneider D, Achenbach CJ, Lloyd-Jones DM, Feinstein MJ.

PLoS One. 2018 Mar 20;13(3):e0194754. doi: 10.1371/journal.pone.0194754. eCollection 2018.

3.

Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity.

Hsu JC, Li Y, Marcus GM, Hsue PY, Scherzer R, Grunfeld C, Shlipak MG.

J Am Coll Cardiol. 2013 Jun 4;61(22):2288-95. doi: 10.1016/j.jacc.2013.03.022. Epub 2013 Apr 3.

4.

Adjudicated Heart Failure in HIV-Infected and Uninfected Men and Women.

Feinstein MJ, Steverson AB, Ning H, Pawlowski AE, Schneider D, Ahmad FS, Sanders JM, Sinha A, Nance RM, Achenbach CJ, Christopher Delaney JA, Heckbert SR, Shah SJ, Hanna DB, Hsue PY, Bloomfield GS, Longenecker CT, Crane HM, Lloyd-Jones DM.

J Am Heart Assoc. 2018 Nov 6;7(21):e009985. doi: 10.1161/JAHA.118.009985.

6.

Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.

Crane HM, Paramsothy P, Drozd DR, Nance RM, Delaney JA, Heckbert SR, Budoff MJ, Burkholder GA, Willig JH, Mugavero MJ, Mathews WC, Crane PK, Moore RD, Eron JJ, Napravnik S, Hunt PW, Geng E, Hsue P, Rodriguez C, Peter I, Barnes GS, McReynolds J, Lober WB, Crothers K, Feinstein MJ, Grunfeld C, Saag MS, Kitahata MM; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort.

JAMA Cardiol. 2017 Mar 1;2(3):260-267. doi: 10.1001/jamacardio.2016.5139. Erratum in: JAMA Cardiol. 2017 Mar 1;2(3):346.

7.

Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Neilan AM, Karalius B, Patel K, Van Dyke RB, Abzug MJ, Agwu AL, Williams PL, Purswani M, Kacanek D, Oleske JM, Burchett SK, Wiznia A, Chernoff M, Seage GR 3rd, Ciaranello AL; Pediatric HIV/AIDS Cohort Study and the International Maternal Adolescent and Pediatric AIDS Clinical Trials Network.

JAMA Pediatr. 2017 May 1;171(5):450-460. doi: 10.1001/jamapediatrics.2017.0141.

8.

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration.

Lancet. 2004 Jul 3-9;364(9428):51-62.

PMID:
15234856
9.

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.

Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG.

Circulation. 2010 Feb 9;121(5):651-8. doi: 10.1161/CIRCULATIONAHA.109.898585. Epub 2010 Jan 25.

10.

Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Butt AA, Chang CC, Kuller L, Goetz MB, Leaf D, Rimland D, Gibert CL, Oursler KK, Rodriguez-Barradas MC, Lim J, Kazis LE, Gottlieb S, Justice AC, Freiberg MS.

Arch Intern Med. 2011 Apr 25;171(8):737-43. doi: 10.1001/archinternmed.2011.151.

11.

Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.

O'Neal WT, Sandesara PB, Samman-Tahhan A, Kelli HM, Hammadah M, Soliman EZ.

Eur J Prev Cardiol. 2017 Jul;24(11):1212-1219. doi: 10.1177/2047487317708676. Epub 2017 May 9.

12.

Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.

Al-Kindi SG, ElAmm C, Ginwalla M, Mehanna E, Zacharias M, Benatti R, Oliveira GH, Longenecker CT.

Int J Cardiol. 2016 Sep 1;218:43-46. doi: 10.1016/j.ijcard.2016.05.027. Epub 2016 May 13.

13.

Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).

Chang PP, Chambless LE, Shahar E, Bertoni AG, Russell SD, Ni H, He M, Mosley TH, Wagenknecht LE, Samdarshi TE, Wruck LM, Rosamond WD.

Am J Cardiol. 2014 Feb 1;113(3):504-10. doi: 10.1016/j.amjcard.2013.10.032. Epub 2013 Nov 9.

14.

U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.

Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne JE, Crane HM, Mugavero MJ, Napravnik S, Kirk GD, Jacobson LP, Brooks JT; North American AIDS Cohort Collaboration on Research and Design.

Ann Intern Med. 2012 Sep 4;157(5):325-35.

15.
16.

Cutaneous malignancies among HIV-infected persons.

Crum-Cianflone N, Hullsiek KH, Satter E, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK.

Arch Intern Med. 2009 Jun 22;169(12):1130-8. doi: 10.1001/archinternmed.2009.104.

17.

HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.

Achenbach CJ, Buchanan AL, Cole SR, Hou L, Mugavero MJ, Crane HM, Moore RD, Haubrich RH, Gopal S, Eron JJ, Hunt PW, Rodriguez B, Mayer K, Saag MS, Kitahata MM; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS).

Clin Infect Dis. 2014 Jun;58(11):1599-606. doi: 10.1093/cid/ciu076. Epub 2014 Feb 12.

18.

Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007.

Zetola NM, Bernstein K, Ahrens K, Marcus JL, Philip S, Nieri G, Jones D, Hare CB, Hsu L, Scheer S, Klausner JD.

BMC Public Health. 2009 Jan 14;9:17. doi: 10.1186/1471-2458-9-17.

19.

Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals.

Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I.

J Clin Hypertens (Greenwich). 2013 Feb;15(2):101-6. doi: 10.1111/jch.12029. Epub 2012 Oct 26.

20.

Effect of persistent moderate viremia on disease progression during HIV therapy.

Raffanti SP, Fusco JS, Sherrill BH, Hansen NI, Justice AC, D'Aquila R, Mangialardi WJ, Fusco GP; Collaborations in HIV Outcomes Research/United States Project.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1147-54.

PMID:
15319674

Supplemental Content

Support Center